Liver diseases, which occur out
of infections, or metabolic diseases as well as autoimmune diseases are fatal.
Majority of the times, injury to the liver leads to excess scarring of the
liver, which is called liver cirrhosis. In this kind of disease, the metabolic
functionality and synthetic functionally of the liver is hampered and it also
results in greater risk of liver cancer. In western countries this diseases is
among the top fatal diseases and the deaths caused by such liver cirrhosis is
also rising at a fast pace. Presently, liver transplantation is the only option
available for Liver cirrhosis Treatment.
The problem with the conventional
Liver cirrhosis Treatment option is the lack of donor organs, as the
supply of donor organs is not able to match the increasing demand of organs for
transplantation. Other than these, immunosuppression and rejection of donor
organs are other complications associated with the traditional treatment
options. This is why scientists and doctors across the globe are involved in
constant research to develop regenerative treatment options for curing such
dangerous disease.
Of late, Stem Cell therapy
has progressed at a fast rate and discovery of pluripotent cells is one of the
latest findings in the ongoing research. These put forward a promise of
generation of unending cells like hepatocyte, which can be used for
transplantation in some of the liver diseases. However, there are many
challenges in the way of developing stem cell based Liver cirrhosis
Treatment, as in this disease the architecture of the liver is disturbed
drastically because of excessive collagen deposition.
The cells, which functions in our
liver are known as hepatocytes. When a liver is in healthy condition, these
cells divides and multiply in number, as a result, new cells generate to take
the place of damaged or dead cells in the liver. When the liver suffers some
kind of injury, another kind of cells called the oval cells lends a hand to
produce hepatocytes. However, in the case of severe injury to the liver, the
process of repairing of damaged cells is affected and scarring of the liver
happens. Traditional treatment options like transplantation are very expensive,
so researchers are studying the safety, efficiency, and feasibility of Stem
Cell therapy that utilize autologous MSCs (Mesenchymal Stem cells) as a
possible Liver
cirrhosis Treatment. A number of such studies being carried out in
different parts of the world have demonstrated that such Stem Cell therapy
was able to suppress liver inflammation and also showed improvement in scarring
along with replenishment of hepatocytes. This has given a new hope for Liver
cirrhosis Treatment in the time to come. In a few clinical trials of Stem
Cell therapy, administration of mesenchymal stem cells has proved to be
safe and bearable and also displayed positive results in patients suffering
from liver cirrhosis.
In the time to come pluripotent
stem cells or embryonic cells might be utilized for generating new hepatocytes
in lab conditions and then will be transplanted back into the patient whose
liver is not able to generate new hepatocytes. Researchers are also exploring
another type of Stem Cell therapy where cells from the bone marrow of
the patient will be used for repairing the injured liver tissues.
No comments:
Post a Comment